Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from THC Biomed INTL ( (TSE:THC) ) is now available.
THC Biomed Intl Ltd., a pioneering licensed cannabis producer in Canada, has received a renewal of its cannabis cultivation and processing license from Health Canada, extending its validity until August 2026. This renewal not only affirms the company’s compliance with regulatory standards but also supports its ongoing efforts to expand its product offerings, including its renowned THC Kiss beverage, dried flower, pre-rolls, and clones, thereby strengthening its position in the Canadian cannabis market.
More about THC Biomed INTL
THC Biomed is a leading cannabis company focused on producing high-quality, diverse cannabis products. The company emphasizes innovation and consumer satisfaction, aiming to meet the evolving needs of cannabis enthusiasts through continuous research, development, and product excellence. It is committed to innovation in genetics, cultivation, and AI-driven automation.
Technical Sentiment Signal: Sell
Current Market Cap: C$3.28M
For detailed information about THC stock, go to TipRanks’ Stock Analysis page.